Effects of an Antioxidant Supplement on Blood Vessel Health

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

MitoQ

MitoQ supplement is composed of mitoquinol mesylate, which is a synthetic analog of coenzyme Q10

DIETARY_SUPPLEMENT

Placebo

MitoQ matched Placebo

DRUG

MitoTempo

During each experimental visit, intradermal microdialysis will be used to locally infuse MitoTempo (a mitochondria-specific superoxide dismutase mimetic) into the cutaneous microvasculature in the ventral aspect of the left forearm.

DRUG

Tempol

During each experimental visit, intradermal microdialysis will be used to locally infuse Tempol (a superoxide dismutase mimetic) into the cutaneous microvasculature in the ventral aspect of the left forearm.

DRUG

L-NAME

During each experimental visit, L-NAME (nitric oxide synthase inhibitor) will be perfused through microdialysis fibers for quantification of nitric oxide-mediated vasodilation.

DRUG

SNP - Sodium Nitroprusside

At the end of each experimental visit, SNP will be perfused through microdialysis fibers to elicit a maximal vasodilation response.

Trial Locations (1)

30602

RECRUITING

Ramsey Student Center, University of Georgia, Athens

All Listed Sponsors
lead

University of Georgia

OTHER